| Product Code: ETC12702703 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Nuclear Medicines Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Nuclear Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Nuclear Medicines Market - Industry Life Cycle |
3.4 Israel Nuclear Medicines Market - Porter's Five Forces |
3.5 Israel Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.7 Israel Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Israel Nuclear Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer and other chronic diseases requiring nuclear medicine treatments |
4.2.2 Technological advancements in nuclear medicine imaging and therapy |
4.2.3 Growing investments in healthcare infrastructure in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for nuclear medicine products and services |
4.3.2 High cost associated with nuclear medicine procedures |
4.3.3 Limited availability of skilled professionals in the field of nuclear medicine |
5 Israel Nuclear Medicines Market Trends |
6 Israel Nuclear Medicines Market, By Types |
6.1 Israel Nuclear Medicines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Nuclear Medicines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Nuclear Medicines Market Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031F |
6.1.4 Israel Nuclear Medicines Market Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031F |
6.2 Israel Nuclear Medicines Market, By Application Area |
6.2.1 Overview and Analysis |
6.2.2 Israel Nuclear Medicines Market Revenues & Volume, By Oncology Imaging, 2021 - 2031F |
6.2.3 Israel Nuclear Medicines Market Revenues & Volume, By Thyroid Treatment, 2021 - 2031F |
6.2.4 Israel Nuclear Medicines Market Revenues & Volume, By Cardiac Imaging, 2021 - 2031F |
6.2.5 Israel Nuclear Medicines Market Revenues & Volume, By Bone Pain Palliation, 2021 - 2031F |
6.3 Israel Nuclear Medicines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Nuclear Medicines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Nuclear Medicines Market Revenues & Volume, By Endocrinology Clinics, 2021 - 2031F |
6.3.4 Israel Nuclear Medicines Market Revenues & Volume, By Cardiology Centers, 2021 - 2031F |
6.3.5 Israel Nuclear Medicines Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4 Israel Nuclear Medicines Market, By Product Type |
6.4.1 Overview and Analysis |
6.4.2 Israel Nuclear Medicines Market Revenues & Volume, By Technetium-99m, 2021 - 2031F |
6.4.3 Israel Nuclear Medicines Market Revenues & Volume, By Iodine-131, 2021 - 2031F |
6.4.4 Israel Nuclear Medicines Market Revenues & Volume, By Thallium-201, 2021 - 2031F |
6.4.5 Israel Nuclear Medicines Market Revenues & Volume, By Samarium-153, 2021 - 2031F |
7 Israel Nuclear Medicines Market Import-Export Trade Statistics |
7.1 Israel Nuclear Medicines Market Export to Major Countries |
7.2 Israel Nuclear Medicines Market Imports from Major Countries |
8 Israel Nuclear Medicines Market Key Performance Indicators |
8.1 Number of new cancer cases diagnosed annually in Israel |
8.2 Adoption rate of advanced nuclear medicine technologies in Israeli healthcare facilities |
8.3 Number of research and development projects focused on nuclear medicine in Israel |
9 Israel Nuclear Medicines Market - Opportunity Assessment |
9.1 Israel Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.3 Israel Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Israel Nuclear Medicines Market - Competitive Landscape |
10.1 Israel Nuclear Medicines Market Revenue Share, By Companies, 2024 |
10.2 Israel Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here